نتایج جستجو برای: adjuvant

تعداد نتایج: 43907  

2017
Masayuki Hayashi Taiki Aoshi Yasunari Haseda Kouji Kobiyama Edward Wijaya Noriyuki Nakatsu Yoshinobu Igarashi Daron M. Standley Hiroshi Yamada Yoshikazu Honda-Okubo Hiromitsu Hara Takashi Saito Toshiyuki Takai Cevayir Coban Nikolai Petrovsky Ken J. Ishii

Advax, a delta inulin-derived microparticle, has been developed as an adjuvant for several vaccines. However, its immunological characteristics and potential mechanism of action are yet to be elucidated. Here, we show that Advax behaves as a type-2 adjuvant when combined with influenza split vaccine, a T helper (Th)2-type antigen, but behaves as a type-1 adjuvant when combined with influenza in...

2012
Keun-Cheol Lee Tae-Heon Kim Su-Seong Park Min-Su Kim Myung-Hoon Kim Seok-Kwun Kim Se-Heon Cho Mi-Ri Lee Jin-Hwa Lee Hyung-Sik Lee Dae-Cheol Kim

BACKGROUND Postmastectomy adjuvant therapy is used to prevent locoregional recurrence and improve overall breast cancer specific survival rates. However, it can adversely affect the cosmetic results of reconstruction. Therefore, the authors examined flap stability and patients' satisfaction with immediate breast reconstruction after adjuvant therapy. METHODS We retrospectively reviewed the me...

Journal: :The Yale Journal of Biology and Medicine 1983
J. T. Rosenbaum R. B. Mandell

Peptidoglycan, the substance in mycobacteria thought to be responsible for inducing adjuvant arthritis, and endotoxin (lipopolysaccharide or LPS) share many inflammatory properties. Since repeated administration of LPS produces tolerance, i.e., resistance to the toxic and inflammatory effects of LPS, we tested whether LPS and/or LPS tolerance might influence inflammation due to mycobacterial ad...

Journal: :Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 2009
Norihiko Ikeda Seisuke Nagase Tatsuo Ohira

Several prospective randomized trials for patients with completely resected stages II and IIIA nonsmall cell lung cancer have confirmed a survival benefit with cisplatin-based adjuvant chemotherapy. The Lung Adjuvant Cisplatin Evaluation, which is based on pooled analyses of five randomized trials, has demonstrated a 4.2% absolute survival benefit at 5 years. The stage is the benchmark standard...

2013
Tobias Janowitz Sarah J. Welsh Kamarul Zaki Peter Mulders Tim Eisen

To date, no effective adjuvant treatment for renal cell carcinoma (RCC) has been described, but research in this area is important since the 5-year relapse rate for intermediate- and high-risk early-stage RCC is 30%-40%. Metastatic RCC can be treated successfully with immune therapy and targeted therapy. Adjuvant trials with immune therapy have been conducted, but they reported no benefit in di...

Leishmaniasis is one of the major health problems and categorized as a class I disease (emerging and uncontrolled) by World Health Organization (WHO), causing highly significant morbidity and mortality. Indeed, more than 350 million individuals are at risk of Leishmania infection, and about 1.6 million new cases occur causing more than 50 thousands death annually. Because of the severe...

2016
Changhoon Yoo Yoon-Koo Kang

Although adjuvant therapy has become the standard of care worldwide for resectable localized gastric cancer, geographic differences exist in standard adjuvant treatments: postoperative chemoradiation in North America, perioperative chemotherapy in Europe, and postoperative chemotherapy in East Asia. Global differences in standard surgical methods or study populations may influence the discrepan...

Journal: :Head & neck 2016
Andrés M Bur Alexander Lin Gregory S Weinstein

Perineural invasion (PNI) is widely regarded as a negative prognostic factor in head and neck squamous cell carcinoma (HNSCC). Treatment guidelines recommend adjuvant radiotherapy (RT) for patients with adverse pathologic features, including PNI. The purpose of this study was to systematically review the literature to determine if patients with PNI as their only indication for adjuvant therapy ...

Journal: :International journal of radiation oncology, biology, physics 2008
Natalie G Coburn Ulrich Guller Nancy N Baxter Alex Kiss Jolie Ringash Carol J Swallow Calvin H L Law

PURPOSE The Southwest Oncology Group/Intergroup 0116 (INT-0116) trial showed that adjuvant chemoradiotherapy improves survival in high-risk gastric adenocarcinoma patients. This study examined the adoption of adjuvant treatment following the trial results and the factors associated with its use. METHODS AND MATERIALS Between 1996 and 2003, patients aged 18-85 years with resected gastric adeno...

Journal: :archives of medical laboratory sciences 0
mohammad hassan pouriayevali taravat bamdad seyed mehdi sadat farzaneh sabahi mohammad reza aghasadeghi

background: the major problem of dna vaccine is less immunogenicity of them verses other killed or live whole organism vaccines therefore adjuvants for use in this kind vaccines is very necessary. genetic adjuvants with bacterial sources are an appropriate approach to modulate immune responses to dna vaccines. listeria monocytogenes proteins such as listeriolysin o (llo) with cd4 and cd8 epitop...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید